Axsome Therapeutics Inc (AXSM) Government Trades - Latest Congressional Stock Transactions
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
top performing (AXSM) trades
Chris Jacobs
House (R-NY)
170.10%
Recent Axsome Therapeutics (AXSM) Trades by Congress Members
See the most up-to-date Axsome Therapeutics trades disclosed by US lawmakers, including purchase and sale amounts, transaction dates, and reporting details. View the most recent Axsome Therapeutics trades made by congress members.
Chris JacobsHouse (R-NY) | $15K - $50K | stock | Purchase | Jul 28, 2022 | Jun 16, 2022 | House |
